Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Skye Peptides.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| BPC-157 | 15 | 98.47% | Aug 30, 2026 |
| Retatrutide | 12 | 99.68% | Apr 22, 2026 |
| Tirzepatide | 12 | 99.7% | May 10, 2026 |
| Semaglutide | 9 | 99.89% | Mar 19, 2025 |
| Tesamorelin | 7 | 95.11% | Aug 26, 2026 |
| Ipamorelin | 6 | 98.84% | Aug 26, 2026 |
| Mazdutide | 5 | 99.41% | Aug 15, 2025 |
| Melanotan II | 4 | 99.3% | Mar 19, 2025 |
| CJC-1295 No DAC | 4 | 98.87% | Mar 19, 2025 |
| Survodutide | 4 | 98.92% | May 20, 2025 |
| CJC-1295 DAC | 3 | 99.22% | May 19, 2025 |
| GHK-Cu | 1 | 99.7% | Aug 30, 2026 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| BPC-157 | BPC26-10-001 | 99.6% | Lab G | Aug 30, 2026 | verify |
| GHK-Cu | GHK25-50-002 | 99.7% | Lab G | Aug 30, 2026 | verify |
| Ipamorelin | IPA25-10-003 | 94.53% | Lab K | Aug 26, 2026 | verify |
| BPC-157 | BPC26-10-001 | 99.34% | Lab K | Aug 26, 2026 | verify |
| BPC-157 | BPC26-10-001 | 98.02% | Lab K | Aug 26, 2026 | verify |
| Tesamorelin | TESA26-10-001 | 83.84% | Lab K | Aug 26, 2026 | verify |
| Tesamorelin | TESA26-10-001 | 85.23% | Lab K | Aug 26, 2026 | verify |
| Tirzepatide | TZ26-10-001 | 99.9% | Lab E | May 10, 2026 | verify |
| Retatrutide | RET26-12-001 | 99.2% | Lab E | Apr 22, 2026 | verify |
| Retatrutide | RET26-24-001 | 99.9% | Lab E | Apr 8, 2026 | verify |
| BPC-157 | BPC25-05-002 | 99.88% | Lab E | Feb 21, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Feb 17, 2026 | verify |
| Tesamorelin | n/a | 99.7% | Lab G | Feb 3, 2026 | verify |
| Ipamorelin | IPA-10-001 | 99.8% | Lab G | Feb 3, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab G | Jan 25, 2026 | verify |
| Tesamorelin | TESA25-10-004 | 98.65% | Lab E | Jan 8, 2026 | verify |
| BPC-157 | BPC25-10-001 | 98.5% | Lab G | Dec 15, 2025 | verify |
| Mazdutide | MZ24-06-001 | 99.83% | Lab F | Aug 15, 2025 | verify |
| Retatrutide | RET25-10-003 | 99.9% | Lab F | Aug 13, 2025 | verify |
| Tesamorelin | n/a | 99.441% | Lab D | Aug 4, 2025 | verify |
| BPC-157 | n/a | 97.92% | Lab E | Jul 23, 2025 | verify |
| Tesamorelin | n/a | 99.86% | Lab E | Jul 23, 2025 | verify |
| Tirzepatide | TIR10N022125 | 99.118% | Lab D | May 20, 2025 | verify |
| Survodutide | SV24-06-001 | 99.027% | Lab D | May 20, 2025 | verify |
| Survodutide | SV24-06-001 | 99.167% | Lab D | May 20, 2025 | verify |
Showing 25 most recent of 82. Search the full database on the CoA page.
Sell or represent Skye Peptides? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/skye-peptides/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/skye-peptides.svg" alt="Skye Peptides: lab tested, 82 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.